Department of Physiology and Membrane Biology, School of Medicine, University of California, Davis, California 95616, USA.
J Cereb Blood Flow Metab. 2013 Feb;33(2):225-34. doi: 10.1038/jcbfm.2012.160. Epub 2012 Nov 14.
Cerebral edema forms in the early hours of ischemic stroke by processes involving increased transport of Na and Cl from blood into brain across an intact blood-brain barrier (BBB). Our previous studies provided evidence that the BBB Na-K-Cl cotransporter is stimulated by the ischemic factors hypoxia, aglycemia, and arginine vasopressin (AVP), and that inhibition of the cotransporter by intravenous bumetanide greatly reduces edema and infarct in rats subjected to permanent middle cerebral artery occlusion (pMCAO). More recently, we showed that BBB Na/H exchanger activity is also stimulated by hypoxia, aglycemia, and AVP. The present study was conducted to further investigate the possibility that a BBB Na/H exchanger also participates in edema formation during ischemic stroke. Sprague-Dawley rats were subjected to pMCAO and then brain edema and Na content assessed by magnetic resonance imaging diffusion-weighed imaging and magnetic resonance spectroscopy Na spectroscopy, respectively, for up to 210 minutes. We found that intravenous administration of the specific Na/H exchange inhibitor HOE-642 significantly decreased brain Na uptake and reduced cerebral edema, brain swelling, and infarct volume. These findings support the hypothesis that edema formation and brain Na uptake during the early hours of cerebral ischemia involve BBB Na/H exchanger activity as well as Na-K-Cl cotransporter activity.
脑水肿在缺血性中风后的早期通过涉及增加 Na 和 Cl 从血液到完整的血脑屏障 (BBB) 内脑的转运而形成。我们之前的研究提供了证据,表明 BBB 钠-钾-氯共转运体受缺血因子缺氧、低糖血症和精氨酸加压素 (AVP) 的刺激,静脉注射布美他尼抑制共转运体可大大减少大鼠永久性大脑中动脉闭塞 (pMCAO) 后的水肿和梗死。最近,我们发现 BBB 钠/氢交换器的活性也受到缺氧、低糖血症和 AVP 的刺激。本研究旨在进一步探讨 BBB 钠/氢交换器是否也参与缺血性中风期间的水肿形成。将 Sprague-Dawley 大鼠进行 pMCAO,然后通过磁共振成像扩散加权成像和磁共振波谱 Na 波谱分别评估脑水肿和 Na 含量,最长可达 210 分钟。我们发现,静脉注射特异性 Na/H 交换抑制剂 HOE-642 可显著减少脑 Na 摄取并减少脑水肿、脑肿胀和梗死体积。这些发现支持以下假设:在脑缺血早期,脑水肿的形成和脑内 Na 摄取涉及 BBB 钠/氢交换器的活性以及钠-钾-氯共转运体的活性。